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Objectives . The present study was undertaken to investigate the
response of large and small coronary arteries in a subgroup of
patients with no or minimal coronary artery disease found to have
objective signs of myocardial ischemia .
Background. Many patients apr'rendy have normal coronary
arteries despite abnormal electrocardiographic (ECG) changes
during spontaneous anginal attacks or exercise stress testing.
Methods . Twenty-five patients with no or minimal (<30%
stenosis) coronary artery disease were chosen from a pool initially
selected on the basis of spoulaneoas anginal attacks and ST
segment shifts in the anterior leads . Of these, 10 were grouped as
having variant angina (at least one episode of ST elevation) and
Ike remaining 15 as having syndrome X (exercise-induced anginal
pain, ST depression and reversible thallium abnormalities) . Data
were compared with those obtained in 10 patients with stable
angina and documented coronary artery disease . Eighteen pa-
tients with supraventricular arrhythmias and normal coronary
arteries served as control patients . Patients showing focal spasm
during ergonovine testing were not included in the subsequent
angiographic analysis . Great cardiac vein blood flow, aortic
pressure and changes in coronary artery diameter were measured
at rest and 2 to 4 min after hyperventilation in the remaining study
Despite a multitude of studies, there is still no consensus on
the pathophysiology of chest pain in patients with angio-
graphically normal coronary arteries (1,2). The term "syn-
drome X" was introduced by Arbogast and Bourassa (3) in
1973 to denote angina-like chest pain associated with ST
segment depression that occurs during atrial pacing in some
patients with normal or near normal coronary arteriograms .
Such patients have a limited coronary flow reserve due to
inappropriate vasoconstriction of the small intramural coro-
nary arteries (4). Accordingly, these patients are regarded as
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group . The same procedure was repeated after sublingual admin-
istration of 0.3 mg of nitroglycerin In eight patients (four with
syndrome X and four with variant angina) .
Results. Hyperventilation induced diffuse epicardial coronary
diameter reduction, which was marginal In control patients (9 t
4%) and those with coronary artery disease (5 ± 3%) but severe
(p < 0.001) in those with variant angina (28 + 14%) or syndrome
X (25 + 13%) . Concomitant determination of coronary blood flow
showed significant (p < 0.001) decreases in those with variant
angina (25 + 11 %) and syndrome X (28 + 10%) but not in control
patients (5 + 3%) or those with coronary artery disease
(4 ± 5%). Changes in great cardiac vein blood flow during
hyperventilation were similar before anv after nitroglycerin.
Conclusions. These findings indicate that vasoconstrictor stim-
uli may trigger a diffuse abnormal response of both epicardial and
resistance vessels in some patients with chest pain and angiograph-
ically normal coronary arteries . Patients showing such diffuse
vasoconstrictor abnormalities are suggested to have a single
pathogenetic entity with a spectrum of ECG manifestations rang-
ing from ST depression to ST elevation .
(J Am Coil Cardiol 1993 ;22:417-25)
separate from those usually referred to as having "variant
angina," which is, conversely, attributed to diffuse vasocon .-
striction (5) or focal spasm (6) of large epicardial vessels,
with an implied different pathogenetic mechanism .
The present study investigated the response of large and
small coronary arteries to vasoconstrictor stimuli in patients
presenting with anginal pain, normal coronary angiograms,
an ischemic-appearing electrocardiographic (ECG) response
to exercise and reversible thallium abnormalities . All pa-
tients fulfilled the criteria for the descriptive category desig-
nated as syndrome X . Data were then compared with those
obtained in two other groups of patients with normal angio-
grams: the first with ischernic heart di^ease and ECG evi-
dence of variant angina, the second with atrioventricular
(AV) node accessory pathways but without ischemic heart
disease . Comparison was also made with data in 10 patients
with stable angina and documented coronary artery disease
.
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Methods
Study patients. Forty-three patients found to have angio-
graphically normal or near normal (<30% stenosis) coronary
arteries during diagnostic cardiac catheterization were stud-
ied
. Of these, 25 presented with chest pain as well as
transient ischemic ST shifts (>0
.15 mV) in the anterior ECG
leads and 18 with episodes of supraventricular tachyarrhyth-
mias. No patient had systemic hypertension, primary car-
diomyopathy, valvular heart disease, including mitral valve
prolapse, or diabetes .
Fifteen of the 25 patients with anginal pain were diag-
nosed as having syndrome X. These patients showed I) a
positive exercise response (anginal pain and >0 .1 mV hori-
zontal or downsloping ST depression) ; 2) no significant ECG
changes during ergonovine testing (total dose 0 .350 mg
intravenously) ; 3) reversible regional perfusion abnormali-
ties during exercise, as assessed by technetium-99m hexa-
mibi or thallium-201 scans, or both ; and 4) reduced coronary
flow reserve (increase in coronary blood flow <50%) during
atrial pacing (140 beats/min). Ten of the 15 patients devel-
oped chest pain only during effort of variable intensity ; the
remaining 5 patients also experienced angina at rest . The
mean age of these 15 patients (12 women and 3 men) was
47 ± 6 years (range 34 to 58) .
The remaining 10 patients with anginal pain and normal
angiograms were diagnosed as having variant angina . All 10
patients had recurrent angina associated with transient ST
elevation occurring spontaneously or during ergonovine
testing. This group (eight men and two women) had a mean
age of 54 ± 5 years (range 40 to 62) .
The 18 patients (6 men and 12 women) with supraventric-
ular tachyarrhythmias were referred to our laboratory for
diagnostic angiographic and electrophysiologic study and
served as control patients . Their age ranged from 28 to 48
years (mean 41 ± 6) .
Ten patients (eight gnen and two women) with a mean age
of 56 ± 6 years, stable effort angina and documented
significant coronary artery disease (>70% atherosclerotic
stenosis) were studied for comparison .
Trial design. Each patient gave written informed consent
for the study. All cardiovascular medications were with-
drawn 48 h before the study, except for sublingual nitroglyc-
erin when required . Long-acting beta-adrenergic blocking
agents were discontinued ~1 week before the study . Diag-
nostic left-sided cardiac catheterization and coronary an-
giography were performed by a standard percutaneous ap-
proach. At least 15 min after completion of the diagnostic
catheterization, patient classification was made and those
eligible for the study were selected by consensus decision .
The catheter used for coronary angiography was positioned
in the aorta to measure pressure with a Statham P25 trans-
ducer. A thermodilution catheter (Wilton Webster Labora-
tories) was introduced percutaneously using the left subcla-
uian approach and positioned in the great cardiac vein to
measure coronary blood flow in the region supplied by the
left anterior descending coronary artery (7). All patients
underwent hyperventilation testing : 30 respirations/min for
5 min . Thereafter, all but those with coronary artery disease
underwent ergonovine testing. The time interval between the
end of hyperventilation and the second control set of mea-
surements was 30 min . Ergonovine was administered intra-
venously in serial doses of 50, 100 and 200 flag at 5-min
intervals . Great cardiac vein blood flow, aortic pressure
measurements and coronary angiograms were recorded be-
fore and l to 2 min after both hyperventilation and ergono-
vine testing. Ischemia during provocative testing was re-
lieved by inhalation of amyl nitrate . The ECG was monitored
with one bipolar lead (CM 3 or CM5) .
Nitroglycerin studies. To quantify the left coronary dila-
tir.a response to nitrates, sublingual nitroglycerin (0.3 mg)
was given to each patient, followed by repeat angiography .
Thereafter, eight patients underwent a further hyperventila-
t:on test: four with syndrome X and four with variant angina .
Patients with syndrome X were randomly selected . Patients
with variant angina were chosen on the basis of their
response to ergonovine; that is, four patients found to
exhibit intense diffuse coronary constriction were consid-
ered eligible for the study. Measurements of great cardiac
vein blood flow were taken throughout the study .
Coronary blood flaw measurements . The thermodilution
technique for determining coronary sinus and great vein
blood flow has previously been described (8) . Because of
concern for right atrial reflux during hyperventilation, great
cardiac vein but not coronary sinus blood flow was recorded
(9) . Anterior coronary vascular resistance was calculated as
the mean aortic pressure divided by the great cardiac vein
flow. To avoid any contrast-induced alteration, flow mea-
surements were performed 215 min after the last angiogram
was performed .
Quantitative angiography. Quantitative coronary angiog-
raphy was performed by a previously validated technique
(10). Briefly, the angiograms were examined by three inves-
tigators and all of the proximal, mid and distal segments (4 to
6 mm) of the left anterior descending and left circumflex
coronary arteries free of vessel overlap and side branches
were chosen for analysis . Selection allowed the analysis of
three to six coronary segments per patient . The selected
cineframes were projected by a Tagarno model 55CX into a
52- x 67-cm screen with an approximately fivefold magnifi-
cation. The borders of the selected coronary artery segments
were then traced by hand and the X-Y coordinates were
digitized and stored in an IBM PC-AT 0386 computer . The
computer program reduced the vessel image to true scale by
compensating for radiographic pincushion distortion out of
plane magnification and optical magnification, using the stem
of the Judkins catheter for calibration to determine absolute
measurements in mm. The accuracy of this method is within
0.10 mm for measurements of known dimensions (11) .
Statistical analysis. Results are expressed as mean value
± SD. Data were analyzed using the Student t test or t test
for respectively paired or unpaired observations . Kruskal-
JACC Vol . 22, No . 2
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Table 1 . Coronary Artery Diameter at Baseline Study and During Interventions
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All values are expressed in ton".
CAD = coronary artery disease
: Var, angina = variant angina found to have diffuse coronary constriction .
Wallis analysis of variance (ANOVA) on ranks, followed by
the Mann-Whitney test, were used for comparison of the
percent changes in coronary artery diameters among the
groups. Statistical significance was assumed at the 0 .05
probability level .
Results
The averaged vessel diameters and standard deviations,
as well as their response to vasomotor stimuli are illustrated
in Table 1 .
Epicardial coronary arteries during provocative testing.
Control patients. All patients had angiographically normal
smooth coronary arteries without Ium411 irregularities . They
showed slight coronary vasoconstriction in response to
hyperventilation (Fig. 1). The mean control vessel diameter
was 2.02 ± 0.72 mm and decreased to 1 .86 ± 0.74 mm (mean
percent change 9 ± 4%) . Similarly, slight coronary artery
vasoconstriction occurred during ergonovine testing, with a
mean recontrol vessel diameter of 2 .00 ± 0.73 mm that
decreased to 1.75 ± 0.66 mm (mean percent change 12 ± 5%)
(Fig. 2) .
Coronary artery disease . After hyperventilation, all pa-
tients with coronary artery disease had mild diffuse coronary
constriction . Segments with significant atherosclerotic in-
volvement were not analyzed. The smooth segments con-
Figure 1 . Percent epicardial coronary
artery constriction of angiographically
normal segments in response to hyper-
ventilation: 90 segments were analyzed
in 18 control patients, 75 segments in 15
patients with syndrome X and 19 seg-
ments in 4 patients with variant angina
found to have diffuse coronary vasocon-
striction (see text) . *p < 0.001 as com-
pared with value in control patients .
stricted from 2.07 ± 0.43 to 1 .96 ± 0.54 mm in response to
hyperventilation (p = NS).
Syndrome X . Again, all patients showed angic ,aohi-
cally normal smooth coronary arteries . Three : :Y€ atz -.with
syndrome X developed anginal pain but not ST segment
shifts during ergonovine testing. None of then- patients had
chest pain or ECG changes during hypervi -Eilation . Both
hyperventilation (Fig. 1) and ergonovine (Feg . 2) caused a
greater degree of vasoconstriction compared with that ob-
served in the 18 control patients . Vasocot ;friction devel-
oped diffusely, even though it was more pr( .z ounced in the
mid-distal part of the vessel (Fig . 3) . Cor=.wary diameter
measured 1.69 ± 0.36 mm before hyperventilation and
1 .09 ± 0.31 mm after testing (mean perce~ - change 25
13%, p < 0.0001). A similar degree of coronary vasocon-
striction was observed during ergonovine testing, with a
mean recontrol diameter of 1 .68 ± 1 .12 mm that decreased to
1 .12 ± 0.34 Inm (mean percent change 26 ± 11%, p <
0.0001) .
Variant angina . In the basal state, the coronary arteries
appeared normal in four patients and not s rreificantly nar-
rowed in six . All but one patient experienced anginal pain
and ST shifts >0.1 mV during provocative testing (9 of 10
patients with ergonovine and 4 of 10 patients with hyperven-
tilation) . Hyperventilation or ergonovine, or both, caused
severe coronary vasoconstriction in all patients. This was
Patient Group Baseline Hyperventilation Baseline Ergonovine
Baseline Nitroglycerin
Coi .trol (n = 18) 2 .02 ± 0.72 1 .86 t 0.74 2 .00 ± 0.73 1 .75 ± 0
.66 1 .98 ± 0 .75
2 .20 ± 0.77
CAD (n = 10) 2 .07 ± 0.43 1 .96 t 0.54
2_01 ± 0 .37 2 .37 ± 0.58
Syndrome X (n = 15) 1 .69 ± 0.36 1 .09 ± 0.31 1 .68± 1
.12 1.12±0 .34
1 .63 ± 1
.38
2 .10 ± 0.49
Var. angina (n = 4) 1 .93 ± 0 .36 1 .24 ± 0.48 1 .93±0
.41 0.92±0 .35 1 .92*_0 .38 2
.48 ± 0.41
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focally occlusive or subocclusive (>50%) in six patients and
diffuse (Fig . 4) in the remaining four patients . Focal occlu-
sive vasoconstriction occurred at the site of preexisting
coronary artery irregularities . Intense and diffuse vasocon-
striction occurred in patients with normal-appearing coro-
nary vessels. Patients showing focal spasm in response to
ergonovire or hyperventilation, or both, were not included
in the segment analysis, which specifically assessed the
average diameter changes in those patients having no dy-
namic or fixed stenosis . In this subset of patients, hyperven-
tilation caused a marked (mean percent change 28 ± 14%)
degree of vasoconstriction (Fig . 1) . The mean control vessel
diameter was 1 .93 ± 0.36 mm, which decreased to 1 .24 ±
0.48 mm after testing (p < 0 .002). Severe coronary vasocon-
striction occurred also during ergonovine testing (p < 0 .001)
(Fig. 2), with a mean recontrol vessel diameter of 1 .93 ±
0.41 mm, which decreased to 0 .92 ± 0.35 mm (mean percent
change 41 ± 17%, p < 0.01 vs. those with syndrome X).
Eplcardlai coronary arteries after nitroglycerin . All coro-
nary arteries dilated in response to nitroglycerin (Fig . 5) . In
the 18 control patients, the mean recontrol vessel diameter
was 1.98 ± 0.75 mm, which increased to 2.20 0.77 mm,
JACC Vol . 22, No . 2
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Figure 2. Epicardial coronary artery
constriction of angiographically nor-
mal segments after ergonovine test-
ing: 83 segments were analyzed in 18
control patients, 78 segments in 15
patients with syndrome X and 19
segments in 4 patients with variant
angina found to have generalized
vasoconstrictor phenomena . *p <
0.001 as compared with control pa-
tients .
with a mean percent change of 14 ± 10% (p < 0 .001). In
patients with coronary artery disease, the smooth segments
dilated from a mean control diameter of 2 .01 ± 0.37 to 2 .37
0.58 mm (p < 0.005, mean percent change 18 ± 11%) .
Coronary vasodilation was greater (p < 0 .001) in patients
with syndrome X (1 .63 ± 0.38 vs. 2.10 ± 0.49 mm) and in
those with variant angina showing diffuse vasoconstriction
during provocative testing (1 .92 ± 0.38 vs . 2 .48 ± 0.41 mm) .
These responses represented a 31 ± 18% and 27 ± 13% mean
percent increase in vessel diameter, respectively .
Coronary blood flow during provocative testing. Changes
in great cardiac vein blood flow were monitored throughout
the study (Table 2) . All patients with significant epicardial
constriction showed significant changes in coronary blood
flow. In those with syndrome X, blood flow decreased from
103 ± 60 to 74 ± 47 ml/min (28 ± 10%, p < 0 .001) after
hyperventilation and from 103 ± 49 to 84 ± 45 ml/min during
ergonovine (p < 0.001). Similarly, in those with variant
angina, flow decrease: with either ergonovine (from 89 ± 24
to 67 ± 21 ml/min) or hyperventilation (from 91 ± 28 to 68 ±
20 ml/min, 25 ± 11%, both p < 0 .001). Coronary blood flow
also do creased in those patients with variant angina who did
Figure 3. Left coronas angiograms obtained
before (left) and 2 min after
(right) hyperventi-
lation in a patient diagnosed as having syn-
drome X .
0
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Figure 4. Left coronary angiograms obtained be-
fore (left) and 2 min after (right) hyperventilation
in a patient diagnosed as having variant angina.
not show focal coronary artery spasm (Patients 2, 7, 9 and
10) (Table 2) . No significant changes in great cardiac vein
flow (p = NS) were found in control patients (from 86 ± 30
to 82 ± 31 milmin) or patients with coronary artery disease
(from 87 ± 33 to 82 ± 30 mUmin) after hyperventilation .
As previously mentioned, eight patients (four with syn-
drome X and four with variant angina, all showing diffuse
vasoconstriction during provocative testing) were then se-
lected to undergo repeat by rcrventilation 15 min after sub-
lingual administration of nitroglycerin (Table 3) . In these
patients, changes in great cardiac vein blood flow paralleled
those observed during hyperventilation before nitroglycerin
administration .
Discussion
The precise mechanism responsible for chest pain in
patients with a normal coronary angiogram is still a matter of
debate . Over the past 10 years, many terms (!2) have been
proposed to label the condition of these patients, including .
"syndrome X'' (3), "variant angina with normal coronary
arteriograms" (13) and "microvascular angina" (14) . Char-
os
go-
70
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acterization of such patients, however, depends on the
extent to which they are studied, usually with special tests
not routinely employed, so that there remains uncertainty
about the size of the problem, comparability of different
series reported, prognosis (15), treatment (16,17) and, in-
deed, about the possible existence of several different un-
derlying causes, as seems increasingly likely .
Selection of patients with angina and normal coronary
arteriograms. Cannon et al., basing their conclusion on
ergonovine (18) and dipyridamole (4) studies, have clearly
demonstrated that some patients who have anginal pain
despite normal epicardial arteries have an exaggerated re-
sponse of small coronary vessels to vasoconstrictor stimuli .
Because angiography during an ergonovine-induced increase
in cororary resistance demonstrated no significant change in
epicardial artery diameters, they concluded that the increase
in resistance was caused only by microvascular constriction .
Accordingly, they proposed the term "microvascular angi-
na" to characterize these patients (14) . Few of their patients,
however, showed ? 1 mm ST segment shift during atrial
pacing or ergonovine testing ; therefore, the majority did not
fulfill the criteria for the descriptive category designated as
$
s
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•
BUGIARDINI ET
AL.
•
• a
•
•
•
SYNDROME X VARIANT ANGINA
a= 19
• i
421
*p < 0 .001 for hyperventilation (HV) and ergonovine ((B) versus baseline (B). tp < 0 .05 for patients with syndrome X versus control patients . $p < 0 .05 for patients with variant angina versus control patients .
*Patients with diffuse vasoconstriction . ACR = anterior coronary resistance (mm Hglmllmin); GCVBF = great cardiac vein blood flow (mi/nun); Pt = patient.
qC
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ronary Hemodynamics During Provocative Testing
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Central Syndrome X Variant Angina
Control Syndrome X Variant Angina
GCVBF ACR GCVBF ACR GCVBF ACR
GCVBF ACR GCVBF ACR GCVBF ACR
Pt
No.
B 13_
a
B HV B HV B HV
B
HV
B E B E B E B E B EB
RVB HV
1 106 79 1.0 1 .42 210 145 0.37 0.42 110 95 0.78
0.87 101 106 1 .0 1 .08 195 168 0.39 0.45 111 78 0.81 1 .20
2 68 68 1 .52 1 .80 198
142
0.60
0.72 594 51 1 .94 2 .37 73 78 1 .62 1 .60 163 142 0.62 0.66 63 56 1 .73
1 .94
3 130
86
0.94 1 .48 180 160 0.56 0.54 101 51 0.99 1 .90 121 115
0.90 0.92 179 155 0.37 0.40 95 71 1 .03 1 .49 0
4 66 85 2.08 1 .57 31 14 3 .25 7.36 102 83
1
.02
1 .38 70 81 2 .00 1 .84 32 28 2.12 2.30 96 67 1 .04
1
.45 y
5 98 98
1 .04
0 .93
58 44 1.87 2.45 135 92 0.35 1 .4B 93 98 1 .10 1 .04 125 111 0
.97
1 .19 131
116 0
.77
0
.86
5
,4
6 44 39 2
.81 3 .23 27 21 3 .74 5.57 111 74 1 .00 1 .43 45 39 2
.78 3
.00
49 35 3 .10 3.30 100 76 1 .06 1 .35
>
7 65 57
2.12 2 .20 122 91 0.61 0.66 539 44 1 .87 2.41 57 65
2 .04 1 .95 97 83 1 .03 1 .15 61 44 1 .59 2 .25
8
64 86 1.48 1 .14 167 109 0.56 0.61 53 48 1 .66
1 .73 69
79
1 .50 1 .45 133 101 0.99 1 .13 56 42 1 .58 2 .23 ?
9 146 156 0.49 OA5 77 51 1 .08 1 .11 97*
76
1.18 1 .61 138
145 0.51 0.48 81 42 1 .45 2.47 90 67 1 .21
1
.67 rn
10 79 69 1.40 1 .60 54 33
1 .73 2
.85
864 68 1 .06 1 .30 69 79 1 .51 1 .46 68 51 . .3 1.51 91 55 0.99
1
.73
11 87 82 1.49 1 .58 112
81
1
.44 2.23 82 86 1.41 1 .40 112 100 1 .23 1 .35
12
86 83 1.50 1 .56 80 50 1 .07 1 .09 89 87 1
.52 1 .54 79 60 1 .43 2 .46
13 71 70 1.50 1 .66 61 46 1
.84 2
.38
75 75 1 .48 1 .50 65 48 2.90 3 .12
14 101 99 1
.10 1 .05
55
40 1.75 2.63 99 106 1 .08 1 .11 59 45 2.71 2 .99
15 70 60 2.01 2.12 117 84 1.30 2.08 60 70 2.00
2
.02 115
97
1
.56
1.75
16 81 70 1.42 1 .63 142 149 0.5
0.42
17 140 150 0.50 0.40 49 49 2.41
2.44
18 45 41 2.Si 2.81 83 74
L40 1.37
Mean 86 82 1.49
1
.59 103
74
.`t
1
.45 2.18*t 91 68'x# 1_18 1 .64*t 84 88 1.41 1 .48 103 84*t 1 .48 1 .74't 89 67*# 1 .18 1 .61*t
-* SD 30 31
0.68 0.70 60 47 0.98 1 .96 28 20 0.49 0.49 28 29 0.60 0.63 49 45 0.86 0 .96 24 21 0.33 0.44
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Table 3 . Coronary Hemodynamics Before and After
Nitroglycerin Administration During
; Hyperventilation
"p < 0.03 . tp < 0.02 . 1p < 0.04 . §p < 0 .001 . Abbreviations as in Table 2 .
syndrome X or variant angina with normal coronary arterio-
grams used in several other studies (1,3,13,15,17) .
The present study dealt with a subset of patients present-
ing with a normal angiogram in whom the development of
pair. was associated with significant ECG repolarizativn
changes. They were initially classified into two distinct
groups: 1) patients diagnosed as having syndrome X-de-
fined as recent typical precordial discomfort, ischemic-
appearing ECG response to exercise and reversible thallium
abnormalities-all of whom had limited coronary blood flow
reserve during atrial pacing ; and 2) patients with a clinical
diagnosis of variant angina-defined as recurrent a .nginal
pain associated with ST elevation . In the latter, the sequen-
tial intravenous administration of ergonovine demonstrated
excellent sensitivity in reproducing symptoms and ST eleva-
tion .
Generalized vasoconstriction of epirardial coronary arter-
ies. A certain degree of generalized vasoconstriction was
expected in all subjects undergoing provocative testing
(19,20), but the precise magnitude of these changes was
unknown. We demonstrated that both ergonovine and hy-
perventilation were able to induce diffuse epicardial coro-
nary diameter reduction, which was marginal (by <15%) in
control subjects but severe (by >25%) in patients we labeled
as having syndrome X. A similar diffuse abnormality in
vasoconstriction was also observed in some patients show-
ing ST elevation but no evidence of focal coronary artery
spasm during ergonovine provocation . These observations
are consistent with previous studies (4,5) but in conflict with
other data by Kasky et al . (19), who reported a normal
epicardial response in those patients they considered to have
syndrome X. Differences in patient selection may explain
these differences . The lack of sensitivity and specificity of
BUGIARDINI ET AL.
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the investigations routinely used leaves much room for
uncertainty. As reported by Kern (21), all of these data
support a heterogeneous subgrouping of patients . Syndrome
X may be one of several synd .: .-omes with or without epicar-
dial vasoconstriction hypers• :nsitivity, depending on the
subgroup examined and the tkme of examination in the
patient's clinical course. In addition, some of our patients
with syndrome X experienced chest pain both at rest and
during effort ; this may explain differences wit'., previous
studies (19) in which typical exertional pain and ST depres-
sion during exercise were the entry criteria. Including rest
pain as one of the entry criteria would select patients more
likely to have coronary hyperreactivity and thus an en-
hanced epicardial response to provocative testing . Why
patients we labeled as having syndrome X and some of those
with variant angina have a greater degree of vasoconstriction
during ergonovine or hyperventilation is unknown, but the
reason may reflect intrinsic differences in the neuroht{moral
axis (22) or depression of endothelium-derived relaxing
factor release (23) . Enhanced neurohumoral discharge may
itself be a potential cause of abnormal vasoconstriction .
Alternatively, sympathetic output may be normal, but vessel
reactivity could be abnormal . The latter is exemplified by a
shift from the normal endothelium-dependent dilator re-
sponse of human coronary arteries to acetylcholine to a
constrictor response in patients with typical chest pain and
normal coronary arteries (23). Endothelial dysfunction could
indeed underlie a nonspecific enhancement of the response
to all vasoconstrictor stimuli . A constrictor response to
intracoronary acetylcholine does not necessarily indicate
endothelial dysfunction, however, because it could equally
be due to enhancement of the direct constrictor response of
vascular smooth muscle (24).
Before Nitroglycerin
After Nitroglycerin
Pt
No
Baseline Hyperventilation
Baseline
Hyperventilation
GCV13F ACR GCVBF
ACR
GCVBF
ACR
GCVBF
ACR
Syndrome X
1 210 0 .39
145 0 .46 198
0.40 150 0 .51
2 195 0 .49
143 0 .67 1
0.53 141 0 .68
3
84 1 .07 67 1 .26
80 0.97
69 1 .1
4 140
0 .70 107 0 .88 131
0.58 96
0.91
Mean 157* 0 .66t 115' 0 .821
149" 0.62$
114* 0.80#
SD 57 0 .30 37 0 .34
55 0.25 38
0.26
Variant Angina
1
104
1 .37 90 1 .92 76
1 .05 65 1 .21
2
55
1 .80 46 2 .28 40 2.35
29 3.10
3
58
1 .89 40 2.34 51 2.13
42 2.61
4 89 1 .02
62
1 .43
75 1 .20 55 1
.61
Mean 77* 1 .52§ 60' 1 .99§ 61t
1 .68 48t 2
.13t
* SD 24 0.40 22 0 .42 18 0.65
16 0.87
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Generalized vasodilation of epicardialf coronary arteries
.
Our findings add another piece of information relative to the
coronary vascular disorder seen in our series of patients
showing diffuse coronary artery constriction
. After the ad-
ministration of nitroglycerin, coronary diameters were often
larger than predicted from those observed before drug
administration compared with values in control patients, a
finding in keeping with previous observations (25) . En-
hanced vasodilation after nitroglycerin could be secondary
to a smaller than usual coronary artery diameter recorded on
the control period angiogram
; it confirms the suggestion of a
higher coronary tone at rest and, hence, increased suscepti-
bility to vasoconstrictor stimuli .
Coronary blood flow and mechanisms of ischemia .
Ordi-
narily, the conductive vessels impart very little resistance to
coronary blood flow . Most of the resistance occurs in the
arteries where there is a major pressure loss before entry
into the capillary system . This is true under normal condi-
tions, but what happens if there is a diffusely abnormal
contraction of the epicardial arteries? To address this issue,
we measured coronary blood flow during hyperventilation
before and after nitrate administration in eight patients
showing severe vasoconstriction during provocative testing .
Four had been documented to exhibit ST depression and
four had ST elevation during Hotter monitoring . There was a
marked decrease in flow after baseline hyperventilation in
both groups . The decrease in blood flow caused by testing
was not prevented by 0.3 mg of sublingual nitroglycerin,
which, conversely, dilated epicardial coronary arteries .
Therapeutic doses of nitroglycerin have large effects on
conductive arteries, but they have little effect on coronary
arteriolar vessels (26) . It therefore seems unlikely that the
degree of epicardial constriction that we observed during
hyperventilation could contribute to the resistance of the
coronary flow in absence of atherosclerotic narrowing . It
follows that the microcirculation is still the major culprit .
Several patients showing generalized vasoconstrictor phe-
nomena developed chest pain during pacing but did not
develop similar discomfort with either hyperventilation or
ergonovine testing. This observation suggests that the mech-
anisms responsible for chest pain in some of these patients
may be more complex than is indicated by explanations
based solely on changes in vasomotor tone. Inappropriate
small vessel constriction may lead to either insufficient
vasodilation or primary reduction of coronary blood flow .
Ischemia, therefore, develops at rest or when myocardial
oxygen Consumption increases . The relative contributions of
these factors may differ from patient to patient and from day
to day, depending on variables such as vessel sensitivity,
patient activity level and the degree and type of vasocon-
strictor stimulation .
Nation between degree of vasoconstriction and flow hmi-
tatlon. As a group, patients having diffuse vasoconstriction
and ST elevation after ergonovine had a greater reduction in
coronary diameter (Fig. 2) than did those showing diffuse
vasoconstriction but no ST shifts . However, patients with-
out ST segment changes had absolute values in flow tha
were similar to those of patients exhibiting ST elevation
Coronary sinus thermodilution has substantial limitation,
that could account for this apparent discrepancy . First,
coronary sinus thermodilution does not define the mass of
myocardium being drained ; therefore, comparison of ther.
modilution values among different patients is difficult with-
out knowledge of left ventricular mass . Second, measure-
ments of great cardiac vein flow by thermodilution provide a
value of total flow for whatever portion of ventricular
drainage entering the coronary venous system upstream to
the flow measurement catheter. The great cardiac vein
contains venous blood draining primarily though not exclu-
sively from myocardium supplied by the left anterior de-
scending coronary artery (7) . This implies that absolute
values for flow normally vary with anatomy and catheter
position, which can differ among patients . However, the
observations that great cardiac vein drainage may or may not
include all left anterior descending artery outflow and that
absolute values of flow may differ in people of different body
sizes do not cause problems when qualitative rather than
quantitative changes in flow in response to interventions are
being assessed . In the present study, great cardiac vein flow
sampling was used accordingly . Coronary flow during pro-
vocative testing showed significant decreases in patients
labeled as having variant angina or syndrome X, but not in
control patients or those with coronary artery disease, which
is consistent with the observation of abnormal coronary
constriction in the former but not the latter.
Vasotonic angina. The causes of coronary microcircula-
tory dysfunction need not be the same in all patients . The
term syndrome X has outlived its usefulness . To add to the
confusion, the term has more recently come to be used for
another syndrome comprising hypertension, insulin resis-
tance and obesity (27) . The syndrome that emerges in the
present study includes a more homogeneous group of pa-
tients characterized by the following features : 1) chest pain
during effort and occasionally at rest ; 2) evidence of isch-
emia as demonstrated by regional myocardial perfusion
defects; 3) inappropriate vasoconstriction of the entire .or-
onary artery tree; and 4) ECG manifestations ranging from
ST depression, as the rule, to ST elevation, as the exception .
In such patients, the abnormality in vasoconstriction of the
epicardial arteries does not cause significant changes in
coronary hemodynamics, which, conversely, are affected by
the concomitant constriction of the intramural arterioles .
These findings do not necessarily imply that severe vasocon-
striction of resistance vessels should always be accompanied
by severe narrowing of epicardial arteries . In some cases,
the functional abnormalities may be exclusive to large or
small arteries ; in others, components of the entire coronary
tree may be involved, as our report indicates .
Within the group of patients thought to have variant
angina, there were two subgroups: one will focal spasm and
one with a diffuse vasoconstrictor response to provocative
testing, the latter being similar to that we observed in
JACC Vol. 22, No . 2
August 1993 :417-25
	
VASOTONIC ANGINA AND NORMAL CORONARY ARTERIES
patients labeled as having syndrome X . . Both the cause and
the clinical significance of the generala~ 44 increase in coro-
nary vasomotility are likely to differ ''!nom those of focal
spasm. Accordingly, heightened sensitivity of both coronary
epicardial and resistance vessels to vasoconstrictor stimuli is
proposed as a distinct pathophysiologic condition . It could
be labeled "vasotonic angina" and may represent one part of
a clinical spectrum of diseases, all of them able to involve the
coronary microcirculation .
Conclusions . Knowledge of underlying pathophysiology
in patients with angina] symptoms and a normal coronary
angiogram is still rudimentary . There is evidence, at least in
some cases, that functional abnormalities may involve not
only small vessels, but also the entire coronary tree and,
possibly, smooth muscle function. Clearer definitions of
specific subgroups of patients with angina-like pain and a
normal coronary arteriogram could allow the identification
of different underlying causes of the disease and effective
treatment .
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